Inactive Instrument

Insiders Alterity Therapeutics Ltd Australian S.E.

Equities

Genetic Technologies Appoints CFO	Mar. 25	MT
Alterity Therapeutics Names Phillip Hains as Chief Financial Officer	Dec. 21	MT
Alterity Therapeutics Limited Announces Resignation of David Sinclair as Non-Executive Directors	22-01-04	CI
Alterity Therapeutics : Dr David Stamler appointed CEO	21-01-06	PU
Alterity Therapeutics Limited Appoints Dr. David Stamler as CEO	21-01-06	CI
Alterity Therapeutics Limited Announces Appointment of Tristan Edwards as Director	19-04-11	CI
Alterity Therapeutics Limited Announces the Cessation of George Mihaly as Director, Effective 8 April 2019	19-04-10	CI
Alterity Therapeutics Limited Announces the Cessation of Ira Shoulson as Director	19-04-10	CI
Prana Biotechnology Limited has Changed its Name to Alterity Therapeutics Limited	19-04-05	CI
Prana Biotechnology Limited Announces Director Appointments	19-04-04	CI
David Sinclair AO and Tristan Edwards to Join the Board of Prana Biotechnology	18-12-28	CI
David Stamler Joins Prana Biotechnology as Chief Medical Officer and Senior Vice President, Clinical Development	17-06-04	CI
Prana Biotechnology Limited Announces Executive Changes	14-11-03	CI
Prana Biotechnology Limited Announces Joining of Ira Shoulson to the Board of Directors as Non Executive Director	14-05-13	CI

No results for this search